Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Pfizer Rep: I Was Fired For Being Pregnant
Pharmalot
Monday, May 21, 2012 - 12:53pm
tags:
Pfizer, gender discrimination, King Pharmaceuticals, drug reps
Sucampo presents data for AMITIZA for treatment of IBS-C
Yahoo/Fly on the Wall
Monday, May 21, 2012 - 12:52pm
tags:
Sucampo, Amitiza, IBS, IBS-C
Outlooks for Pfizer, Arena and Onyx Following Busy May
TheStreet.com
Monday, May 21, 2012 - 12:28pm
tags:
Pfizer, Arena Pharmaceuticals, Onyx, lorcaserin, JAK3 inhibitors, Merck, Carfilzomib
4 Reasons To Buy Ventrus Biosciences
Seeking Alpha
Monday, May 21, 2012 - 12:23pm
tags:
Ventrus
What You Must Know Before Investing in Prostate Cancer Stocks
Minyanville
Monday, May 21, 2012 - 12:22pm
tags:
prostate cancer, Dendreon, Cougar Biotechnology, JNJ, Medivation, Exelixis
FDA staff sends mixed message on J&J drug Xarelto
Reuters
Monday, May 21, 2012 - 12:20pm
tags:
FDA, JNJ, Xarelto, bloodthinners
Auxilium, GlaxoSmithKline enter co-promotion agreement for Testim
Yahoo/Fly on the Wall
Monday, May 21, 2012 - 12:19pm
tags:
GSK, Testim, Auxilium, testosterone
Bristol-Myers Squibb's Thud Heard Round the World
Motley Fool
Monday, May 21, 2012 - 12:19pm
tags:
Bristol-Myers Squibb, Plavix, bloodthinners, Sanofi, Dr Reddy's, generics, Sun Pharma
BioPharm Systems to Host Webinar on Merging Multiple Drug Safety and Pharmacovigilance Databases Into One Global Oracle Argus Safety System
Health Care Global
Sunday, May 20, 2012 - 12:37pm
tags:
BioPharm Systems
Sucampo Pharmaceuticals, Inc. : Sucampo Presents Data for AMITIZA® in the Treatment of Moderate to Very Severe Irritable Bowel Syndrome with Constipation (IBS-C)
4-Traders
Sunday, May 20, 2012 - 12:35pm
tags:
Sucampo, Amitiza, irritable bowel syndrome
AstraZeneca looks to revive experimental drugs
Financial Times, UK
Sunday, May 20, 2012 - 12:34pm
tags:
AstraZeneca, R&D
China Biotech Week In Review: J&J Actively Pursuing M&A In China
Seeking Alpha
Sunday, May 20, 2012 - 12:33pm
tags:
JNJ, M&A, China National Biotech Group, Zhejiang Conba Pharma, Ningbo David Medical Device Co, Ventac Partners, Shanxi Zhendong Pharmaceutical Company, Bristol-Myers Squibb, Novozymes Biopharma, Zhejiang Hisun Pharma, ThermoDox
GlaxoSmithKline completes transaction to increase its ownership in Theravance
PharmPro
Sunday, May 20, 2012 - 12:28pm
tags:
GSK, Theravance, M&A
US bioethics centre queried about ties to drug industry
BioEdge
Sunday, May 20, 2012 - 12:26pm
tags:
painkillers, pain management
JacksonWhite Files Overtime Lawsuit Against Quintiles Commercial U.S., Inc.
Business Review Europe
Sunday, May 20, 2012 - 12:24pm
tags:
overtime lawsuits, lawsuits
Abbott Is Cheap, But AbbVie Will Likely Be Cheaper
Seeking Alpha
Sunday, May 20, 2012 - 11:51am
tags:
Abbott Laboratories, AbbVie
Noteworthy Insider Buys Last Week In 2 Beaten Down Biotechs, With 4 Other Buys And Sells
Seeking Alpha
Saturday, May 19, 2012 - 12:36pm
tags:
Halozyme, Novavax, Prolor, Valeant Pharmaceuticals, Myrexis, OPKO Health, Vertex Pharmaceuticals, Edwards Lifesciences, Medivation, Biomarin, Mylan
PA32540 Provides Faster Gastric Acid Reduction Than Enteric-Coated Omeprazole (40 Mg)
The Street
Saturday, May 19, 2012 - 12:29pm
tags:
PA32540, Omeprazole, Pozen
US FDA okays Ambit Biosciences & Teva's IND for CEP-32496, a novel BRAF inhibitor
Pharmabiz
Saturday, May 19, 2012 - 12:26pm
tags:
Ambit Biosciences, Teva Pharmaceuticals, CEP-32496, cancer, melanoma, lung cancer, thyroid cancer, colon cancer, ovarian cancer
FDA Delays Takeda's Replacement for Actos
Injury Board
Saturday, May 19, 2012 - 12:22pm
tags:
Takeda, Actos, alogliptin, diabetes

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.